MedPath
HSA Approval

APO-ATORVASTATIN TABLET 20 MG

SIN14403P

APO-ATORVASTATIN TABLET 20 MG

APO-ATORVASTATIN TABLET 20 MG

September 5, 2013

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C10AA05

atorvastatin

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC.

APOTEX INC. (Etobicoke Site)

Active Ingredients

ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE 22MG EQV ATORVASTATIN

20 MG

Atorvastatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.